SEC Filing Details
Document Details
Form
Filing Date
May 4, 2023
Document Date
May 2, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Theravance Biopharma
Issuer
Theravance Biopharma, Inc.
Filer
O'Connor Donal